Mauna Kea Technologies announces the opening of Italy's first center of excellence for the use of Cellvizio in the identification and treatment of food intolerance in adult patients suffering from irritable bowel syndrome (IBS).

The Cellvizio food intolerance test (C-FIT) is now in use at the UPMC Salvator Mundi International Hospital in Rome, making Italy the third country to open a Cellvizio Center of Excellence, after the USA and Germany.

Mauna Kea points out that the number of patients seeking solutions for food intolerance is particularly high in Italy, with over one million Internet searches in this field per month, more than in Germany and France.

Copyright (c) 2024 CercleFinance.com. All rights reserved.